In late September 2024, global leaders gathered in New York City for the second United Nations General Assembly High-level Meeting (UNGA HLM) on Antimicrobial Resistance. Since the first UNGA HLM on Antimicrobial Resistance in 2016, the United States (U.S.) has made tremendous progress toward the goals in the U.S. National Action Plan for Combating Antibiotic-resistant…
Improving patient access is often a heavy lift for healthcare providers thanks to staffing shortages, lack of thorough staff training, inefficient processes and more. Experian Health’s State of Patient Access 2024 survey found that curating accurate patient information also continues to be a challenge, which is the primary cause of denied claims for almost half (49%)…
This chart collection explores how health spending is expected to grow in coming years, with a look at growth in prescription drug spending, out-of-pocket spending, and related trends.
This opinion article was originally published in STAT: A failing health care system caused my husband’s death. His care team was incredibly kind, but they lacked the resources to save his life. On Tuesday, September 17, the Centers for Disease Control and Prevention, the Centers for Medicare and Medicaid Services, and the Agency for Healthcare…
‘What the Health?’ are the Health Implications of the Election? The Event: A live taping of ‘What the Health?’, KFF Health News’ premier policy news podcast Moderator Julie Rovner, chief Washington correspondent, KFF Health News Panelists Ashley Kirzinger, director of survey methodology and associate director of the Public Opinion and Survey Research Program, KFF Cynthia…More
This chart collection draws on recent KFF poll findings to provide an in-depth look at the public’s attitudes toward prescription drugs and their prices. Results include Americans’ opinions on drug affordability, pharmaceutical companies, and various potential measures that could lower prices, including the Inflation Reduction Act.
Claim denials are a well-documented challenge for healthcare organizations. Denied claims take much longer to pay out than first-time claims, if they get paid at all. Each one means additional hours of rework and follow-up, pulling in extra resources as staff review payer policies and figure out what went wrong. It’s time-consuming and costly. Beyond…
This policy watch examines monthly premiums for Medicare Part D stand-alone drug plans in 2025, as changes to the Part D benefit are being implemented in 2025, including a new $2,000 cap on out-of-pocket drug spending.
This fact sheet identifies key U.S. government global health positions and officials.
This KFF tracker provides up to date information on U.S. pledges thus far to four multilateral health replenishments (the Pandemic Fund, WHO, Gavi, and the Global Fund) and U.S. government support to date.